NCT02236910 2024-10-15
Lu-DOTA-TATE
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2 Unknown
Clinical Trials
166 trialsNCT06121752 2024-10-15
DNET
Asian Institute of Gastroenterology, India
Phase NA Unknown
NCT03612232 2024-08-19
CaboACC
Wuerzburg University Hospital
Phase 2 Unknown
NCT06156020 2024-03-21
Outcome Analysis of Endoscopic Resection of Pituitary Adenomas
National Cheng-Kung University Hospital
Phase NA Unknown
NCT06321692 2024-03-20
Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications
European Institute of Oncology
Phase NA Unknown
NCT04354324 2024-03-15
Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma
Zhujiang Hospital
Phase NA Unknown
NCT05475210 2024-03-13
177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors
Molecular Targeting Technologies, Inc.
Phase 1 Unknown
NCT06217848 2024-01-23
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Seoul National University Hospital
Phase EARLY_PHASE1 Unknown
NCT00415233 2023-12-19
HiLo
University College, London
Phase 3 Unknown
NCT05709171 2023-11-22
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
Rigshospitalet, Denmark
Phase 2 Unknown
NCT05523778 2023-11-02
A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct
Peking Union Medical College Hospital
Phase NA Unknown
NCT04447183 2023-10-23
DTC
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 2 Unknown
NCT04964284 2023-10-23
Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3 Unknown
NCT05545852 2023-10-18
A Clinical Study of Transaxillary Endoscopic and Open Thyroidectomy for PTC
Nanfang Hospital, Southern Medical University
Phase NA Unknown
NCT04858867 2023-10-10
RESET
Leiden University Medical Center
Phase NA Unknown
NCT06062563 2023-10-02
Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital
Phase NA Unknown
NCT04979611 2023-09-21
The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
First Affiliated Hospital of Fujian Medical University
Phase 1 Unknown
NCT04897542 2023-09-18
Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT05921396 2023-09-07
Nasal Obstruction Compared by Rhinomanometry and Nasal Inspiratory Peak Flow After Endoscopic Nasal Surgery
University Hospital Ostrava
Phase NA Unknown
NCT05102292 2023-08-21
The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation
Shanghai Henlius Biotech
Phase 1/2 Unknown
NCT05815069 2023-08-08
[18F]AlF-NOTA-pentixather PET/CT in Patients With Suspected Primary Hyperaldosteronism
Sichuan Provincial People's Hospital
Phase NA Unknown
NCT05839483 2023-07-17
CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis
Zhongnan Hospital
Phase NA Unknown
NCT05739812 2023-07-14
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery
The Affiliated Hospital of Qingdao University
Phase NA Unknown
NCT05137210 2023-07-06
IDEaL
University of California, Los Angeles
Phase NA Unknown
NCT04878601 2023-06-26
Innovative Strategies to Increase ART Initiation and Viral Suppression Among HIV-positive Men in Malawi
University of California, Los Angeles
Phase NA Unknown
NCT05885399 2023-06-02
The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment
Peking Union Medical College Hospital
Phase 2 Unknown
NCT05885386 2023-06-01
A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL
Peking Union Medical College Hospital
Phase 2 Unknown
NCT05883085 2023-05-31
A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL
Peking Union Medical College Hospital
Phase 2 Unknown
NCT02687958 2023-05-30
Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2 Unknown
NCT04858243 2023-05-15
Engaging Men Through HIV Self-Testing With Differentiated Care to Improve ART Initiation and Viral Suppression Among Men in Malawi
University of California, Los Angeles
Phase NA Unknown
NCT03048877 2023-04-12
Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital
Phase 3 Unknown
NCT05513469 2023-04-07
Radio-Marker
Erasmus Medical Center
Phase NA Unknown
NCT05787145 2023-03-28
ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology Treatment
Ciusss de L'Est de l'Île de Montréal
Phase NA Unknown
NCT03475953 2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2 Unknown
NCT05747729 2023-02-28
A Single-arm, Open-label, Clinical Trial of Surufatinib/Serplulimab/Platinum/Etoposide in Neuroendocrine Carcinoma.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1/2 Unknown
NCT02693067 2023-02-08
A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver
Provectus Pharmaceuticals
Phase 1 Unknown
NCT05466357 2023-02-06
Application Research on Endoscopic Pseudocapsule-Based Resection for Pituitary Adenomas
Affiliated Hospital of Nantong University
Phase NA Unknown
NCT05647954 2022-12-13
A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver
Taizhou Hanzhong biomedical co. LTD
Phase 3 Unknown
NCT05627427 2022-11-25
Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT00986661 2022-11-02
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Provectus Pharmaceuticals
Phase 1 Unknown
NCT05595759 2022-10-27
Violence Against Women in Patients With Alcohol Substance Addiction Training
Abant Izzet Baysal University
Phase NA Unknown
NCT05034783 2022-10-14
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT05554744 2022-09-27
EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors
Guangxi Medical University
Phase NA Unknown
NCT03478358 2022-08-31
Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors
Peking Union Medical College Hospital
Phase 1 Unknown
NCT04525638 2022-08-02
A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours
Fundación de investigación HM
Phase 2 Unknown
NCT04756635 2022-07-26
Performance
Faculdade de Motricidade Humana
Phase NA Unknown
NCT05319704 2022-04-08
Speed-Enso
University Hospital, Clermont-Ferrand
Phase NA Unknown
NCT02817945 2022-04-07
Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT02637531 2022-04-04
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
Infinity Pharmaceuticals, Inc.
Phase 1 Unknown
NCT03732495 2022-03-29
LENVOS
Centre Leon Berard
Phase 2 Unknown